Anticholinergics and Antihistamines

Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose, Fourth Edition

Volumn , Issue , 2007, Pages 721-734

  Kirk, Mark A ^a   Baer, Alexander B ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Rockingham Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650050725     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0693-4.50044-X     Document Type: Chapter

References (95)

1. DA Labianca and WJ Reeves (1984) Scopolamine: a potent chemical weapon. J Chem Educ 61 678-680.
2. K Beaver and T Gavin (1998) Treatment of acute anticholinergic poisoning with physostigmine. Am J Emerg Med 16(5), 505-507.
3. Centers for Disease Control and Prevention (1996) Scopolamine poisoning among heroin users—New York City, Newark, Philadelphia, and Baltimore, 1995 and 1996. MMWR Morb Mortal Wkly Rep 45 457-460.
4. A Weiner, M Bayer, C McKay, et al. (1998) Anticholinergic poisoning with adulterated intranasal cocaine. Am J Emerg Med 16(5), 517-520.
5. T Chan (1995) Anticholinergic poisoning due to Chinese herbal medicines. Vet Hum Toxicol 37(2), 156-157.
6. JH Brown and P Taylor (1996) Muscarinic receptor agonists and antagonists. JG Hardman, LE Limbird (Eds) Goodman and Gilman's The Pharmacological Basis of Therapeutics New York: McGraw-Hill 141-160.
7. N Brown and L Roberts (2001) Histamine, bradykinin, and their antagonists. JG Hardman, LE Limbird (Eds) Goodman and Gilman's The Pharmacological Basis of Therapeutics New York: McGraw-Hill 645-667.
8. RC Hall, J Fox, SK Stickney and ER Gardner (1978) Anticholinergic delirium: etiology, presentation, diagnosis and management. J Psychedelic Drugs 10 237-241.
9. RC Hall, DL Feinsilver and RE Holt (1981) Anticholinergic psychosis: differential diagnosis and management. Psychosomatics 22 581-587.
10. AJ Hvizdos, JA Bennet, BG Wells, et al. (1983) Anticholinergic psychosis in a patient receiving usual doses of haloperidol, desipramine, and benztropine. Clin Pharm 2 174-178.
11. J Cole (1972) Atropine-like delirium and anticholinergic substances. Am J Psychiatry 128 898-899.
12. PA Forrester (1975) An anticholinergic effect of general anaesthetics on cerebrocortical neurones. Br J Pharmacol 55 275-278.
13. GA Woodward and RN Baldassano (1988) Topical diphenhydramine toxicity in a five year old with varicella. Pediatric Emerg Care 4 18-20.
14. JF Reilly and ME Weisse (1990) Topically induced diphenhydramine toxicity. J Emerg Med 8 59-61.
15. F Filloux (1986) Toxic encephalopathy caused by topically applied diphenhydramine. J Pediatr 108 1018-1020.
16. JA Wilkinson (1987) Side effects of transdermal scopolamine. J Emerg Med 5 389-392.
17. BH Price (1985) Anisocoria from scopolamine patches. JAMA 253 1561.
18. JH Patterson, T Ives and MA Greganti (1986) Transient bilateral pupillary dilation from scopolamine discs. Drug Intell Clin Pharm 20 986-987.
19. H Thompson (1971) Cornpicker's pupil: Jimson weed mydriasis. J Iowa Med Soc 61(8), 475-477.
20. D Reid and JD Fulton (1989) Tachycardia precipitated by topical homatropine. BMJ 299 795-796.
21. DA Fitzgerald, RM Hanson and C West (1990) Seizures associated with 1% cyclopentolate eyedrops. J Paediatr Child Health 26 106-107.
22. DA Brizer and DW Manning (1982) Delirium induced by poisoning with anticholinergic agents. Am J Psychiatry 139 1343-1344.
23. L Goldfrank, N Flomenbaum, N Lewin, et al. (1982) Anticholinergic poisoning. Clin Toxicol 19 17-25.
24. SC Dilsalver (1988) Antimuscarinic agents as substance of abuse: a review. J Clin Psychopharmacol 8 14-22.
25. JM Smith (1980) Abuse of the antiparkinson drugs: a review of the literature. J Clin Psychiatry 41 351-354.
26. JG Modell, R Tandon and TP Beresford (1989) Dopaminergic activity of the antimuscarinic antiparkinsonian agents. J Clin Psychopharmacol 9 347-351.
27. W Land, D Pinsky and C Salzman (1991) Abuse and misuse of anticholinergic medications. Hosp Commun Psychiatry 42 580-581.
28. K MacVicar (1977) Abuse of antiparkinsonian drugs by psychiatric patients. Am J Psychiatry 134 809-811.
29. GP Pullen, NR Best and J Maguire (1984) Anticholinergic drug abuse: a common problem. BMJ 289 612-613.
30. JA Crawshaw and PA Mullen (1984) A study of benzhexol abuse. Br J Psychiatry 145 300-303.
31. MB Benjamin (1992) Mushroom poisoning in infants and children: the Amanita Pantherina/Muscaria Group. Clin Toxicol 30 13-22.
32. P Taylor and JH Brown (1989) Acetylcholine. GJ Siegel (Eds) Basic Neurochemistry: Molecular, Cellular, and Medical Aspects New York: Raven 203-231.
33. AC Cuello and MV Sofroniew (1984) The anatomy of the CNS cholinergic neurons. Trends Neurosci 7 74-78.
34. HJ Schneck and J Rupreht (1989) Central anticholinergic syndrome in anesthesia and intensive care. Acta Anaesthesiol Belg 40 219-228.
35. JP Green (1994) Histamine. GJ Siegel (Eds) Basic Neurochemistry: Molecular, Cellular, and Medical Aspects New York: Raven 309-318.
36. EW Gefland (2002) Role of histamine in the pathophysiology of asthma: immunomodulatory and anti-inflammatory activities of the H1-receptor antagonists. Am J Med 113(9A), 2s-7s.
37. BS Sastry and JW Phillis (1976) Depression of rat cerebral cortical neurons by H1 and H2 histamine receptor agonists. Eur J Pharmacol 38 269-273.
38. RF Clark and MV Vance (1992) Massive diphenhydramine poisoning resulting in a wide-complex tachycardia: successful treatment with sodium bicarbonate. Ann Emerg Med 21 318-321.
39. FE Simons and KJ Simons (1994) The pharmacology and use of H1-receptor-antagonist drugs. N Engl J Med 330 1663-1670.
40. G Briggs, R Freeman and S Yaffe (2002) Drugs in Pregnancy and Lactation 6th ed. Philadelphia: Lippincott Williams & Wilkins
41. DJ Greenblatt and RI Shader (1973) Anticholinergics. N Engl J Med 288 1215-1217.
42. JM Gowdy (1972) Stramonium intoxication: review of symptomatology in 212 cases. JAMA 221 585-587.
43. PJ Perry, DC Wilding and RP Juhl (1978) Anticholinergic psychosis. Am J Hosp Pharm 35 725-727.
44. CM Fisher (1991) Visual hallucinations on eye closure associated with atropine toxicity. A neurological analysis and comparison with other visual hallucinations. Can J Neurol Sci 18 18-27.
45. AL Johnson, LE Hollister and PA Berger (1981) The anticholinergic intoxication syndrome: diagnosis and treatment. J Clin Psychiatry 42 313-316.
46. W Klein-Schwartz and GM Oderda (1984) Jimson weed intoxication in adolescents and young adults. Am J Dis Child 138 737-739.
47. A Moreau, BD Jones and V Banno (1986) Chronic central anticholinergic toxicity in manic depressive illness mimicking dementia. Can J Psychiatry 31 339-340.
48. M Richmond and D Seger (1985) Central anticholinergic syndrome in a child: a case report. J Emerg Med 3 453-456.
49. M Burns, C Linden, A Graudins, et al. (1999) A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med 35(4), 374-381.
50. L Tuomisto and U Tacke (1986) Is histamine an anticonvulsive inhibitory transmitter? Neuropharmacology 25 955-958.
51. Z Chen, W-D Li, L-J Zhu, et al. (2002) Effects of histidine, a precursor of histamine, on phenylenetetrazole-induced seizures in rats. Acta Pharmacol Sin 23(4), 361-366.
52. H Yokoyama, M Sato, K Iinuma, et al. (1996) Centrally acting histamine H1 antagonists promote the development of amygdala kindling in rats. Neurosci Lett 217 194-196.
53. H Yokoyama, K Onodera, K Iinuma and T Watanabe (1994) 2-Thia-zolylethylamine, a selective histamine H1 agonist, decreases seizure susceptibility in mice. Pharmacol Biochem Behav 47 503-507.
54. R Scherkl, A Hashem and H Frey (1991) Histamine in brain—its role in regulation of seizure susceptibility. Epilepsy Res 10 111-118.
55. J Markowitz and R Brown (1987) Seizures with neuroleptics and antidepressants. Gen Hosp Psychiatry 9 135-141.
56. P Donlon and J Tupin (1977) Successful suicides with thioridazine and mesoridazine. Ach Gen Psychiatry 34 955-957.
57. SC Curry, D Chang and D Conner (1989) Drug- and toxin-induced rhabdomyolysis. Ann Emerg Med 18 1068-1084.
58. J Glauser (2000) Tricyclic antidepressant poisoning. Cleve Clin J Med 67(10), 709-713.
59. P Fahy, P Arnold, SC Curry and R Bond (1989) Serial serum drug concentrations and prolonged anticholinergic toxicity after benztropine (Cogentin) overdose. Am J Emerg Med 7 199-202.
60. AS Manoguerra and E Ruiz (1976) Physostigmine treatment of anticholinergic poisoning. J Am Coll Emerg Physicians 5 125-127.
61. BE Magera, CJ Betlach, AP Sweatt and CW Derrick (1981) Hydroxyzine intoxication in a 13-month-old child. Pediatrics 67 280-283.
62. JS Gillick (1974) Atropine toxicity in a neonate. Br J Anaesth 46 793-794.
63. E Homsi, M Barreiro, J Orlando and E Higra (1997) Prophylaxis of acute renal failure in patients with rhabdomyolysis. Ren Fail 19(2), 283-288.
64. CA Lindsay, GD Williams and DL Levin (1995) Fatal adult respiratory distress syndrome after diphenhydramine toxicity in a child: a case report. Crit Care Med 23 777-781.
65. LK Danze and MI Langdorf (1991) Reversal of orphenadrine-induced ventricular tachycardia with physostigmine. J Emerg Med 9 453-457.
66. M Farrell, M Heinrichs and JA Tilelli (1991) Response of life threatening dimenhydrinate intoxication to sodium bicarbonate administration. Clin Toxicol 29 527-535.
67. A Sharma, A Hexdall, E Chang, et al. (2003) Diphenhydramine-induced wide complex dysrhythmia responds to treatment with sodium bicarbonate. Am J Emerg Med 21(3), 212-215.
68. RS Freedberg, GR Friedman, RN Palu and F Feit (1987) Cardiogenic shock due to antihistamine overdose: reversal with intra-aortic balloon counterpulsation. JAMA 257 660-661.
69. RP Granacher, RJ Baldessarini and E Messner (1976) Physostigmine treatment of delirium induced by anticholinergics. Am Fam Physician 13 99.
70. BH Rumack (1973) Anticholinergic poisoning: Treatment with physostigmine. Pediatrics 52 449-451.
71. JS Burks, JE Walker, BH Rumack and JE Oh (1974) Tricyclic antidepressant poisoning. Reversal of coma, choreoathetosis, and myoclonus by physostigmine. JAMA 230 1405-1407.
72. RC Duvoisin and R Katz (1968) Reversal of central anticholinergic syndrome in man by physostigmine. JAMA 206 1963.
73. S Nattel, L Bayne and J Ruedy (1979) Physostigmine in coma due to drug overdose. Clin Pharmacol Ther 25 96.
74. K Knudsen and A Heath (1984) Effects of self poisoning with maprotiline. BMJ 288 601-603.
75. WE Walker, RC Levy and IB Henenson (1976) Physostigmine—its use and abuse. J Am Coll Emerg Physicians 5 335.
76. A Schneir, S Offerman, B Ly, et al. (2003) Complications of diagnostic physostigmine administration to emergency department patients. Ann Emerg Med 42(1), 14-19.
77. R Levy (1977) Arrhythmias following physostigmine administration in Jimson weed poisoning. J Am Coll Emerg Physicians 6 107.
78. MW Dysken and DS Janowsky (1985) Dose-related physostigmine induced ventricular arrhythmia: case report. J Clin Psychiatry 46 446-447.
79. RA Munoz and JB Kuplic (1975) Large overdoses of tricyclic antidepressants treated with physostigmine salicylate. Psychosomatics 16 77-78.
80. P Pentel and CD Peterson (1980) Asytole complicating physostigmine treatment of tricyclic antidepressant overdose. Ann Emerg Med 9 588-590.
81. G Isbister, P Oakley, I Whyte and A Dawson (2001) Treatment of anticholinergic-induced ileus with neostigmine. Ann Emerg Med 38(6), 689-693.
82. E Nilsson, OA Meretoja and P Neuvonen (1983) Hemodynamic responses to physostigmine in patients with a drug overdose. Anesth Analg 62 885-888.
83. J Berlin, A King, K Tutsch, et al. (1994) A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma. Invest New Drugs 12 137-141.
84. H Spiller, D Villalobos, B Benson, et al. (2002) Retrospective evaluation of cetirizine (Zyrtec) ingestion [Letter]. Clin Toxicol 40(4), 525-526.
85. J Mason, R Reynolds and N Rao (1999) The systemic safety of fexofenadine HCl. Clin Exp Allergy 29(Suppl 3), 163-170.
86. W Crumb (2000) Loratadine blockage of K (+) channels in human hear, comparison with terfenadine under physiological conditions. J Pharmacol Exp Ther 292 261-264.
87. D Abernathy, J Barbey, J Franc, et al. (2001) Loratadine and terfenadine interaction with nefazodone, both antihistamines are associated with QTc prolongation. Clin Pharmacol Ther 69 96-103.
88. W Kreutner, J Chiu and A Barnett (2000) Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. Second communication, lack of central nervous system and cardiovascular effects. Arzneimittelforschung 50 441-448.
89. I Paakkari (2002) Cardiotoxicity of new antihistamines and cisapride [Review]. Toxicol Lett 127 279-284.
90. CI Berul and M Morad (1995) Regulation of potassium channels by nonsedating antihistamines. Circulation 91 2220-2225.
91. JJ Schentag (1980) Cimetidine-associated mental confusion: further studies in 36 severely ill patients. Ther Drug Monit 2 133-142.
92. EP Krenzelok, T Litovitz and KP Lippold (1987) Cimetidine toxicity: an assessment of 881 cases. Ann Emerg Med 16 1217-1221.
93. A Bleich, A Dycian, M Koslowsky, et al. (1992) Psychiatric implications of missile attacks on a civilian population. JAMA 268(5), 613-615.
94. RC Baselt (2004) Disposition of Toxic Drugs and Chemicals in Man 7th ed. Foster City, CA: Biomedical Publications
95. KE Thummal and DD Shen (2001) Design and optimization of dosage regimens. JG Hardman, LE Limbird, AG Gilman (Eds) Goodman & Gilman's The Pharmacological Basis of Therapeutics 10th ed. New York: McGraw-Hill 1924-2023.